Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | TPST Tempest Therapeutics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $0.82 -2.2% | $15.90 -2.5% |
| StockIQ Score | 51C- Moderate Risk: Medium | 41D Weak Risk: High |
| Technical | 17F | 36F |
| Fundamental | 50C- | 35F |
| Growth | 71B | 50C- |
| Fair Value | 55C | 38F |
| News | 100A+ | 50C- |
| Quality | 55C | 50C- |
| Risk | 46D+ | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Tempest Therapeutics (TPST) outperforms Ascentage Pharma (AAPG) in nearly every category. TPST has a stronger investor score (51 vs. 41), higher growth (71 vs. 50), and better valuation (55 vs. 38). Its technical score (17) is weaker, but its overall rating is "Moderate" compared to AAPG’s "Weak." TPST shows more promise in growth potential and investor confidence.
